Link Therapeutics
Kyoto
About Link Therapeutics
Link Therapeutics specializes in developing therapeutic methods for targeting autoantibodies and identifying pathogenic autoantibodies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $5.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2025)
- Website: link-therapeutics.com
Industries & Categories
Emergency Medicine, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/link-therapeutics-78075 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.